JMP Securities raised the firm’s price target on Xometry (XMTR) to $42 from $34 and keeps an Outperform rating on the shares. The stock ...

JMP Securities raised the firm’s price target on Dave (DAVE) to $115 from $75 and keeps an Outperform rating on the shares. Dave’s ...

Analysts raised their Flutter stock price targets after the FanDuel parent made more modest cuts to its year-end guidance ...

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

JMP Securities raised the firm’s price target on Atlanticus (ATLC) to $54 from $45 and keeps an Outperform rating on the ...

On Wednesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.66 which represents a decrease of $-0.18 or -6.34% from the prior close of $2.84. The stock opened at $2.88 and ...

JMP Securities lowered the firm’s price target on Angi Inc. (ANGI) to $3 from $3.25 and keeps an Outperform rating on the ...

Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market ...

On Wednesday, Savara Inc (SVRA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.58 or -15.14% from the prior close of $3.83. The stock opened at $3.67 and touched a low ...

Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “market outperform” rating reissued by equities researchers at JMP Securities in a report issued on Tuesday,Benzinga reports. They ...

Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...